Citigroup »

Compass Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 13k 1.56
2023-09-30 $361 183 1.97
2023-03-31 $467k 143k 3.27
2022-12-31 $635k 126k 5.03
2022-09-30 $10k 4.5k 2.21
2021-12-31 $120k 38k 3.17